The purpose of this study is to compare two different dosing strategies of a drug named protamine.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
130
250 mg of protamine intravenously (IV), one time use
1mg of protamine per 100 units of heparin given intravenously (IV), one time use
University of Miami Hospital
Miami, Florida, United States
University of Miami
Miami, Florida, United States
Activated Clotting Time
Activated clotting times will be measured using standard coagulation monitor
Time frame: Baseline (before start of surgery)
Activated Clotting Time
Activated clotting times will be measured using standard coagulation monitor
Time frame: up to 4 hours (after cardiopulmonary bypass surgery)
Additional Protamine Dosing
Additional protamine dose will be measured in milligrams (mg)
Time frame: Up to 4 hours
Chest Tube Output
Measured in milliliters (ml)
Time frame: Up to 24 hours
Count of Participants Receiving Red Blood Cell Transfusion
All transfusions were recorded in a data log for the count of participants that received a red blood cell transfusion.
Time frame: Up to 4 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.